New York Times: What to expect when a coronavirus vaccine arrives
Audiences are reliving contributions by UC's Albert Sabin as part of historical vaccine talk
An article in today’s New York Times discusses the contributions of UC’s famed doctor Albert Sabin, who developed the live oral polio vaccine.
In 1958, “the federal government approved an oral polio vaccine, developed by Sabin’s laboratory in Cincinnati, containing weakened, not inactivated, virus,” states the article. “By the end of that year, polio infections were down 90 percent from 1955 levels. In 1979, the country recorded its last community-transmitted case.
"Today, decades into a global vaccination campaign, polio persists in just three countries. The battle against the disease has been a century-long march. And it has required a sustained commitment to continuing polio vaccination — a commitment now compromised as global polio vaccination efforts have been put on hold to slow the coronavirus’s spread."
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Stay up on all UC's COVID-19 stories, read more #UCtheGood content, or take a UC virtual visit and begin picturing yourself at an institution that inspires incredible stories.
Related Stories
Make way for Wawa
June 6, 2025
Wawa opened its doors to Liberty Township this spring to long lines and fanfare. The gas station and c-store’s expansion into greater Cincinnati comes just months after rival Sheetz opened its first southern Ohio location in Franklin. The Cincinnati Business Courier sought out University of Cincinnati professor Michael Jones’ insights on what it means for hometown giant, UDF.
UC College of Medicine students honored as Physicians of Tomorrow
June 6, 2025
Two UC College of Medicine students, Delia Sosa and Lauren Schaffer, have been awarded the prestigious AMA Foundation Physicians of Tomorrow scholarship, recognizing their leadership, advocacy and vision for the future of health care.
Ohio medical regulators raise concerns over retail IV therapy...
June 6, 2025
On May 15, the State Medical Board of Ohio, Ohio Board of Pharmacy and Ohio Board of Nursing issued a joint regulatory statement addressing patient safety concerns when it comes to retail IV therapy clinics. The clinics administer a combination of saline, vitamins, electrolytes and amino acids, as well as headache relief and anti-nausea medications through an intravenous drip. Clinics in the Cincinnati area have made claims that their treatments can treat dehydration better than water alone, while also boosting immunity, improving gut health and maintaining healthy joints. On Cincinnati Edition recently, experts talked about the risks associated with retail IV hydration and if these services offer effective solutions to the health concerns they target.